These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6381872)

  • 41. Allogeneic peripheral blood stem cell rescue of late graft failure after bone marrow transplantation in patients with aplastic anemia.
    Chung IJ; Lee JJ; Park MR; Kook H; Cho SH; Hwang TJ; Kim HJ
    J Korean Med Sci; 2002 Aug; 17(4):468-74. PubMed ID: 12172040
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Campath-1G in vivo confers a low incidence of graft-versus-host disease associated with a high incidence of mixed chimaerism after bone marrow transplantation for severe aplastic anaemia using HLA-identical sibling donors.
    Hamblin M; Marsh JC; Lawler M; McCann SR; Wickham N; Dunlop L; Ball S; Davies EG; Hale G; Waldmann H; Gordon-Smith EC
    Bone Marrow Transplant; 1996 May; 17(5):819-24. PubMed ID: 8733704
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Progress in bone marrow transplantation in acute leukemia and aplastic anemia].
    Speck B; Cornu P; Sartorius J; Nissen C; Gratwohl A; Burri HP; Jeannet M
    Schweiz Med Wochenschr; 1979 Dec; 109(47):1883-5. PubMed ID: 43594
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bone marrow transplantation for severe aplastic anemia.
    Lin KH; Chen YC; Lin DT; Lui LT; Wang CH; Lin KS
    J Formos Med Assoc; 1993 Dec; 92(12):1070-5. PubMed ID: 7911356
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Pichert G; Roy DC; Gonin R; Alyea EP; Bélanger R; Gyger M; Perreault C; Bonny Y; Lerra I; Murray C
    J Clin Oncol; 1995 Jul; 13(7):1704-13. PubMed ID: 7602361
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute graft-versus-host disease after allogeneic bone marrow transplantation.
    Perreault C; Gyger M; Boileau J; Bonny Y; Cousineau S; Lacombe M; Lavallee R; Tawil E; D'Angelo G
    Can Med Assoc J; 1983 Nov; 129(9):969-74. PubMed ID: 6367917
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Close simulation of acute graft-versus-host disease by interleukin-2 administered after autologous bone marrow transplantation for hematologic malignancy.
    Massumoto C; Benyunes MC; Sale G; Beauchamp M; York A; Thompson JA; Buckner CD; Fefer A
    Bone Marrow Transplant; 1996 Mar; 17(3):351-6. PubMed ID: 8704686
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blood versus marrow hematopoietic allogeneic graft.
    Robinet E; Lapierre V; Tayebi H; Kuentz M; Blaise D; Tiberghien P
    Transfus Apher Sci; 2003 Aug; 29(1):53-9. PubMed ID: 12877895
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro analysis of donor bone marrow following monoclonal antibody treatment for the prevention of acute graft versus host disease.
    Kohler PC; Erickson C; Finlay JL; Trigg ME; Edwards B; Hong R; Hank JA; Billing R; Bozdech M; Sondel PM
    Cancer Res; 1986 Oct; 46(10):5413-8. PubMed ID: 3530439
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Allogeneic bone marrow transplantation for severe aplastic anemia: the Vancouver experience.
    Cuthbert RJ; Shepherd JD; Nantel SH; Barnett MJ; Reece DE; Klingemann HG; Chan KW; Spinelli JJ; Sutherland HJ; Phillips GL
    Clin Invest Med; 1995 Apr; 18(2):122-30. PubMed ID: 7788957
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lung diseases after bone marrow transplantation. Results of a clinical, radiological, histological, immunological and lung function study.
    Link H; Reinhard U; Walter E; Wernet P; Schneider EM; Fischbach H; Blaurock M; Wilms K; Niethammer D; Ostendorf P
    Klin Wochenschr; 1986 Jul; 64(13):595-614. PubMed ID: 3528653
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A sequential study of histological and immunological changes in the skin after allogenic bone marrow transplantation.
    Guyotat D; Mauduit G; Chouvet B; Kanitakis J; Van HV; Fiere D; Thivolet J
    Transplantation; 1986 Mar; 41(3):340-2. PubMed ID: 3082048
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human T lymphocyte phenotypes after bone marrow transplantation. T cells expressing Ia-like antigen.
    Hansen JA; Atkinson K; Martin PJ; Storb R; Longton G; Thomas ED
    Transplantation; 1983 Sep; 36(3):277-81. PubMed ID: 6351369
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A prospective study of cellular and immunologic changes in skin of allogeneic bone marrow recipients. Relationship to clinical and histologic features of acute graft-versus-host disease.
    Norton J; Sloane JP
    Am J Clin Pathol; 1994 May; 101(5):597-602. PubMed ID: 8178766
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
    Winston DJ; Antin JH; Wolff SN; Bierer BE; Small T; Miller KB; Linker C; Kaizer H; Lazarus HM; Petersen FB; Cowan MJ; Ho WG; Wingard JR; Schiller GJ; Territo MC; Jiao J; Petrarca MA; Tonetta SA
    Bone Marrow Transplant; 2001 Jul; 28(2):187-96. PubMed ID: 11509937
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A single centre experience with allogeneic stem cell transplantation for severe aplastic anaemia in childhood.
    Ladenstein R; Peters C; Minkov M; Emminger-Schmidmeier W; Mann G; Höcker P; Hawliczek R; Rosenmayr A; Fink FM; Niederwieser D; Gadner H
    Klin Padiatr; 1997; 209(4):201-8. PubMed ID: 9293451
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acute graft versus host disease due to T lymphocytes recognizing a single HLA-DPB1*0501 mismatch.
    Gaschet J; Lim A; Liem L; Vivien R; Hallet MM; Harousseau JL; Even J; Goulmy E; Bonneville M; Milpied N; Vié H
    J Clin Invest; 1996 Jul; 98(1):100-7. PubMed ID: 8690780
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Allogeneic bone marrow transplantation in the treatment of hematologic diseases.
    Yee GC; McGuire TR
    Clin Pharm; 1985; 4(2):149-60. PubMed ID: 3886273
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The cellular composition of human lymph nodes after allogenic bone marrow transplantation: an immunohistological study.
    Dilly SA; Sloane JP; Psalti IS
    J Pathol; 1986 Nov; 150(3):213-21. PubMed ID: 3543275
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bone marrow transplantation for severe aplastic anemia: the Barcelona Hospital Clinic experience.
    Hernández-Boluda JC; Marín P; Carreras E; Aguilar JL; Grañena A; Rozman C; Montserrat E
    Haematologica; 1999 Jan; 84(1):26-31. PubMed ID: 10091390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.